New Targetable Oncogenes in Non–Small-Cell Lung CancerGeoffrey R. Oxnard, Pasi A. Jänne, Adam Binder|Journal of Clinical Oncology|2013Cited by 298
Glanzmann's thrombasthenia: meeting the anticoagulation challengeAdam Binder, Louis M. Aledort|Haemophilia|2015Cited by 8
Interim analysis of LimiTec, a prospective trial of limited-duration teclistamab for relapsed/refractory multiple myelomaBeatrice M. Razzo, Alfred L. Garfall, Leonard Fiannaca et al.|Blood|2025Cited by 6